Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England Read more about Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference Read more about Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nyxoah Appoints John Landry as Chief Financial Officer Read more about Nyxoah Appoints John Landry as Chief Financial Officer
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 Read more about Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update Read more about DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Nyxoah to Participate in Upcoming Investor Conferences Read more about Nyxoah to Participate in Upcoming Investor Conferences
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device Read more about Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024 Read more about Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024
Nyxoah Appoints Scott Holstine as Chief Commercial Officer Read more about Nyxoah Appoints Scott Holstine as Chief Commercial Officer
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Read more about Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA